ArticleClinical drug investigation2023

Comment on: "Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Deep Dutta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.